Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -63,745 | -46,703 | -27,948 | -13,861 | -153,723 |
| Depreciation Amortization | 1,978 | 1,491 | 1,001 | 500 | 68,335 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -12,661 |
| Accounts receivable | -108 | 129 | 96 | 132 | 227 |
| Other Working Capital | 431 | -90 | -1,420 | -4,040 | -2,225 |
| Other Operating Activity | 10,003 | 8,745 | 4,017 | 1,816 | 29,041 |
| Operating Cash Flow | $-51,441 | $-36,428 | $-24,254 | $-15,453 | $-71,006 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -12,180 | 64,048 | 21,036 | -2,401 | 28,916 |
| PPE Investments | -229 | -77 | -66 | N/A | -578 |
| Net Acquisitions | -2,500 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -28,904 | N/A | N/A | N/A |
| Investing Cash Flow | $-14,909 | $35,067 | $20,970 | $-2,401 | $28,338 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 86,746 | 66,536 | 17,440 | 12,481 | 18,908 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 18,549 |
| Financing Cash Flow | $86,746 | $66,536 | $17,440 | $12,481 | $37,457 |
| Exchange Rate Effect | 56 | -56 | -56 | -10 | 68 |
| Beginning Cash Position | 31,799 | 31,799 | 31,799 | 31,799 | 36,942 |
| End Cash Position | 52,251 | 96,918 | 45,899 | 26,416 | 31,799 |
| Net Cash Flow | $20,452 | $65,119 | $14,100 | $-5,383 | $-5,143 |
| Free Cash Flow | |||||
| Operating Cash Flow | -51,441 | -36,428 | -24,254 | -15,453 | -71,006 |
| Capital Expenditure | -229 | -77 | -66 | N/A | -589 |
| Free Cash Flow | -51,670 | -36,505 | -24,320 | -15,453 | -71,595 |